Skip to Main Content

Paper Details

Molecular and Serologic Diagnostic Technologies for SARS-CoV-2.
ArXiv
0
2022
COVID-19, SARS-CoV, SARS-CoV-2
Author NameAffiliation
Halie M RandoUniversity of Pennsylvania, University of Colorado School of Medicine, United States of America Center for Health AI, United States of America Funded by the Gordon and Betty Moore Foundation (GBMF 4552) the National Human Genome Research Institute (R01 HG010067).
Christian BruefferLund University
Ronan LordanInstitute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, University of Pennsylvania Philadelphia
Anna A DattoliThe Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania
David ManheimUnited States of America Risk and Health Communication Research Center, School of Public Health, University of Haifa, Israel Institute of Technology, Israel Funded by Center for Effective Altruism
Jesse G MeyerMedical College of Wisconsin, United States of America Funded by National Institute of General Medical Sciences (R35 GM142502).
Ariel I MundoUniversity of Arkansas
Dimitri PerrinQueensland University of Technology
David MaiUniversity of Pennsylvania, USA Center for Cellular Immunotherapies, Perelman School of Medicine, and Parker Institute for Cancer Immunotherapy at University of Pennsylvania
Nils WellhausenUniversity of Pennsylvania
Anthony GitterUniversity of Wisconsin-Madison, United States of America Morgridge Institute for Research, United States of America Funded by John W. and Jeanne M. Rowe Center for Research in Virology.
Casey S GreeneUniversity of Pennsylvania, Alex's Lemonade Stand Foundation, University of Colorado School of Medicine, United States of America Center for Health AI, United States of America Funded by the Gordon and Betty Moore Foundation (GBMF 4552) the National Human Genome Research Institute (R01 HG010067).
  • 1 - 12

Datasets